GeminIQ Website Logo

Viewing ASRT free

Subscribe for full history, 50+ metrics, screener, watchlist...

Assertio Holdings, Inc.

ASRT

Companies in Pharmaceutical Preparations

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
341039473551384581737770
Short Term Investments
3853555152495144-0--
Accounts Receivable Net Current
62120141616654454043486242
Inventory Net
232425333938403939384319
Prepaid Expense And Other Assets Current
1194182110810111233
Assets Current
167217264210214203181178172171185134
Property Plant And Equipment Net
000111111111
Deferred Income Tax Assets Net
---------0082
Intangible Assets Net Excluding Goodwill
4349556271809299106111170185
Goodwill
----------20-
Other Assets Noncurrent
111111223344
Assets
211267320274286285276279282286380405
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
691511915131516131911
Customer Refund Liability Current
6299131868276605858585943
Accrued Liabilities Current
181416313319131515182210
Business Combination Contingent Consideration Liab…
-0011133331315
Long Term Debt Current
---------000
Other Liabilities Current
555444111110
Liabilities Current
921281671331291159092929311479
Long Term Debt Noncurrent
393939393939393939393938
Other Liabilities Noncurrent
5689101017161616186
Business Combination Contingent Consideration Liab…
---------01628
Liabilities
136173214180178164145147147148187151
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
798797797796795794793792791790787569
Retained Earnings Accumulated Deficit
-722-703-692-703-687-673-663-660-656-652-594-315
Stockholders Equity
769410693109121131132134138193254
Liabilities And Stockholders Equity
211267320274286285276279282286380405
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
200200200200200200200200200200200200
Common Stock Shares Issued
669696966191191190189189226
Shares Outstanding
979696969696959595959557
Stockholders Equity Note Stock Split Conversion Ra…
-0----------

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20264.18%-----------
20256.45%4.84%14.52%9.59%24.66%1.37%-3.75%-23.83%-1.83%53.10%91.16%99.15%
2024-18.85%1.64%23.77%-4.07%-4.07%-14.63%10.59%3.53%-5.88%-19.23%-16.67%-15.38%
2023-9.03%-22.35%-18.62%0.92%-21.71%-34.86%-46.48%-49.77%-58.69%2.15%10.75%6.45%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.82
1.70
1.58
1.59
1.66
1.77
2.01
1.93
1.87
1.83
1.62
1.68
Quick Ratio
1.45
1.44
1.41
1.20
1.19
1.34
1.48
1.39
1.33
1.30
1.22
1.41
Working Capital
75.28M
89.13M
96.79M
77.68M
84.72M
87.86M
91.05M
85.67M
80.03M
77.62M
70.67M
54.07M
Leverage & Debt
Debt to Equity
1.79
1.84
2.02
1.93
1.64
1.35
1.11
1.11
1.10
1.08
0.97
0.59
Interest Coverage TTM
-8.68
-7.00
-6.09
-9.91
-8.77
-8.05
-28.53
-354.29
-
-217.06
-82.38
7.60
Debt Ratio
0.64
0.65
0.67
0.66
0.62
0.57
0.53
0.53
0.52
0.52
0.49
0.37
Efficiency & Turnover
Asset Turnover TTM
0.41
0.43
0.46
0.42
0.42
0.44
0.38
0.39
0.41
0.43
0.48
0.46
Days Sales Outstanding TTM
228.34
267.85
247.47
157.42
167.01
148.65
155.87
112.55
114.44
111.63
115.41
97.91
Receivables Turnover TTM
1.60
1.36
1.47
2.32
2.19
2.46
2.34
3.24
3.19
3.27
3.16
3.73
Per Share Metrics
Diluted EPS TTM
-5.55
-4.74
-4.07
-6.77
-4.80
-3.40
-10.77
-54.35
-52.58
-70.10
-34.14
20.90
Free Cash Flow Per Share TTM
-1.10
-4.40
2.08
2.82
1.00
4.16
3.22
3.64
5.33
10.32
12.79
20.61
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
70.33%
70.19%
68.16%
67.87%
69.89%
68.61%
70.31%
72.12%
76.96%
82.23%
86.24%
87.94%
Operating Profit Margin TTM
-26.21%
-18.14%
-16.94%
-32.27%
-28.04%
-19.59%
-34.45%
-203.16%
-177.77%
-160.15%
-118.38%
20.31%
Net Profit Margin TTM
-34.94%
-25.59%
-21.06%
-36.97%
-25.72%
-17.27%
-54.46%
-261.08%
-234.40%
-218.28%
-109.78%
58.15%
Growth Metrics
Net Revenue Growth (1Y)
-14.15%
-5.00%
9.21%
-11.41%
-16.23%
-17.83%
-25.78%
-21.33%
-12.40%
-2.67%
21.71%
28.78%
Net Income Growth (1Y)
16.59%
40.75%
-57.77%
-87.46%
-90.81%
-93.50%
-63.18%
-453.19%
-442.99%
-402.80%
-824.35%
287.10%
EPS Growth (1Y)
15.57%
39.61%
-58.16%
-87.55%
-90.87%
-95.15%
-68.45%
-308.20%
-284.19%
-300.37%
-527.09%
219.06%
Calculated Values
Free Cash Flow TTM
-7.08M
-28.18M
13.33M
18.07M
6.36M
26.41M
20.47M
23.08M
33.77M
48.87M
69.69M
77.15M
Net Debt
5.54M
28.90M
666.00K
-8.04M
3.93M
-11.78M
859.00K
-6.01M
-42.12M
-34.93M
-38.02M
-31.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-10Sale
Owner: Stark, David Matthew
Title: -
Shares: 8,959
Price/Share: $0.76
Value: $6,808.84
Shares Owned: 98,541
Relationship: Director
Ownership: Direct
2024-11-18Purchase
Owner: Mason, Heather L
Title: -
Shares: 75,000
Price/Share: $0.80
Value: $60,000.00
Shares Owned: 287,650
Relationship: Director
Ownership: Direct
2024-11-14Purchase
Owner: O'Grady, Brendan P.
Title: CEO
Shares: 11,706
Price/Share: $0.85
Value: $9,950.49
Shares Owned: 11,706
Relationship: Director,Officer
Ownership: Direct
2024-06-11Purchase
Owner: Vacirca, Jeff L
Title: -
Shares: 10,000
Price/Share: $1.11
Value: $11,100.00
Shares Owned: 151,159
Relationship: Director
Ownership: Direct
2024-06-05Purchase
Owner: Mason, Heather L
Title: Interim Executive Officer
Shares: 25,000
Price/Share: $0.97
Value: $24,250.00
Shares Owned: 212,650
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
38.72%
Inst. Shares: 2,491,437
Shares Outstanding: 6,434,000
2025-12-31
30.74%
Inst. Shares: 1,968,504
Shares Outstanding: 6,403,000
2025-09-30
25.72%
Inst. Shares: 1,650,117
Shares Outstanding: 6,416,333
2025-06-30
25.88%
Inst. Shares: 1,656,065
Shares Outstanding: 6,398,000
2025-03-31
26.50%
Inst. Shares: 1,690,437
Shares Outstanding: 6,378,000

Assertio Holdings, Inc. (ASRT) — SEC Financial Statements & Analysis

Assertio Holdings, Inc. (ASRT) is a pharmaceutical preparations company, incorporated in DE. Assertio Holdings, Inc. trades on Nasdaq as: ASRT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Assertio Holdings, Inc. reported a -14.15% year-over-year revenue growth, a Gross Profit Margin of 70.33% (TTM), a Debt-to-Equity ratio of 1.79x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-14.15%
Gross Profit Margin TTM
70.33%
Debt To Equity
1.79x

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Assertio Holdings, Inc. in?

Assertio Holdings, Inc. (ASRT) operates in the Pharmaceutical Preparations industry.

What exchange does ASRT trade on?

Assertio Holdings, Inc. (ASRT) trades on the Nasdaq.

Where is Assertio Holdings, Inc. incorporated?

Assertio Holdings, Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

Assertio Holdings, Inc. (ASRT) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.